<DOC>
	<DOCNO>NCT01536392</DOCNO>
	<brief_summary>The goal clinical research study compare granisetron ( give patch ) ondansetron ( take mouth ) reduce nausea vomit woman cervical , endometrial , vaginal cancer chemoradiation . Granisetron ondansetron design help reduce nausea vomiting .</brief_summary>
	<brief_title>Oral Ondansetron Versus Transdermal Granisetron ( Sancuso ) Women With Cervical , Endometrial Vaginal Cancer Receiving Pelvic Chemoradiation</brief_title>
	<detailed_description>Study Groups : If agree take part study , among first 40 participant , equal chance either group . If enroll , high chance ( 51 % -100 % ) assign group well result . - If Group 1 , receive granisetron patch . - If Group 2 , receive ondansetron mouth . Study Drug Administration : If Group 1 , receive ondansetron vein first visit , standard care . Then , receive cisplatin vein 1 hour part chemoradiation . A granisetron patch place skin chemotherapy . The patch replace every 7 day chemotherapy . If Group 2 , receive ondansetron vein cisplatin . Then , receive cisplatin vein 1 hour . Then take ondansetron mouth cup water ( 8 ounce ) 3 time day 3 day . Ondansetron tablet take without food best take least 30 minute eat . Both group give study drug diary record time take study drug . You also record nausea vomiting may . You bring diary study visit . You also bring study drug bottles/packages study visit . Study Visits : The visit study time chemoradiation therapy visit 5 week . You complete 3 questionnaire study visit 1 week last chemotherapy . The last questionnaire complete phone . The questionnaire ask easy difficult use assign study drug , level nausea vomiting , quality life . It take 5 minute complete questionnaire time . Length Treatment : You may continue use study drug 5 week chemoradiation treatment . You longer able take study drug disease get bad , intolerable side effect occur , unable follow study direction . Your participation study complete 5 week chemoradiation treatment . This investigational study . Both granisetron ondansetron FDA approve commercially available treatment nausea vomit . It investigational compare drug administer different way . Up 150 patient take part study . Up 120 participant take part MD Anderson . Up 30 enrolled Harris Health System .</detailed_description>
	<mesh_term>Vaginal Neoplasms</mesh_term>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Granisetron</mesh_term>
	<mesh_term>Ondansetron</mesh_term>
	<criteria>1 . Women cervical , endometrial vaginal cancer dispositioned receive primary postoperative adjuvant pelvic radiation therapy concurrent cisplatin administration . 2 . Women must least 18 year age . 3 . Women must able read English Spanish sixth grade level . 4 . Women childbearing potential must negative pregnancy test within 1 week start chemoradiation therapy . 1 . Women cervical , endometrial vaginal cancer receive chemotherapy and/or radiation therapy recurrent disease . 2 . Women cervical , endometrial , vaginal cancer receive extend field radiation therapy . 3 . Women cervical , endometrial vaginal cancer receive chemotherapy and/or radiation therapy palliative setting . 4 . Women cervical , endometrial , vaginal cancer already receive first dose chemotherapy radiation 7 day prior start chemotherapy .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Cancer Cervix</keyword>
	<keyword>Anti-emetic therapy</keyword>
	<keyword>Granisetron</keyword>
	<keyword>Transdermal patch</keyword>
	<keyword>Ondansetron</keyword>
	<keyword>Zofran</keyword>
	<keyword>Questionnaires</keyword>
	<keyword>Surveys</keyword>
	<keyword>Study Drug Diary</keyword>
</DOC>